Elite Pharmaceuticals Inc (ELTP): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2024-03-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$22.82M
Year ended 2026-03-31
$17.53M
Trailing 12 months to 2026-06-30
2022-03-31: $6.01M2023-03-31: -$2.40M2024-03-31: -$4.04M2025-03-31: $5.83M2026-03-31: $22.82M$22.82M
2022-03-31 Free Cash Flow (USD) 2026-03-31
Period endedFree Cash FlowChange YoYSource filing
2026-03-31$22.82M+291.4%2026-06-29, From 2025-04-01
2025-03-31$5.83Mn/m2026-06-29, From 2024-04-01
2024-03-31-$4.04Mn/c2025-06-30, From 2023-04-01
2023-03-31-$2.40Mn/m2024-07-01, From 2022-04-01
2022-03-31$6.01Mn/a2023-06-29, From 2021-04-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Elite Pharmaceuticals Inc (ELTP)2026-03-31$22.82M+291.4%
Macrogenics Inc (MGNX)2025-12-31-$82.95Mn/m
Karyopharm Therapeutics Inc. (KPTI)2025-12-31-$75.37Mn/m
Heron Therapeutics, Inc. (HRTX)2025-12-31-$27.91Mn/m
Liquidia Corp (LQDA)2025-12-31-$40.02Mn/m
Lifecore Biomedical, Inc. (LFCR)2025-05-25-$13.62Mn/m
Syndax Pharmaceuticals Inc (SNDX)2025-12-31-$323.17Mn/m
Phathom Pharmaceuticals, Inc. (PHAT)2025-12-31-$167.00Mn/m
Cryoport, Inc. (CYRX)2025-12-31-$25.02Mn/m

Compare ELTP, MGNX, KPTI, HRTX side by side · Screen every company in Pharmaceutical Preparations ↗